The detailed analysis and recommendations of the UN Millennium Project Task Forces 4 and 5 are presented in a series of in-depth reports.

Monterrey Consensus
Link to the Monterrey Consensus, adopted in March 2002 at the International Conference on Financing for Development, held on 18-22 March 2002 in Monterrey, N.L., Mexico. This United Nations-sponsored conference on key financial and development issues attracted 50 Heads of State or Government, over 200 ministers as well as leaders from the private sector, civil society and all the major intergovernmental financial, trade, economic, and monetary organizations.

Report of the World Summit on Sustainable Development
Link to the final agreement endorsed by all UN Member States at the World Summit on Sustainable Development held from 26 August to 4 September in Johannesburg, South Africa.

We the Peoples: The Role of the United Nations in the 21st Century
Link to a report by United Nations Secretary-General Kofi Annan in preparation for the 2000 Millennium Summit. "We the Peoples" sets out a practical vision for the UN in a globalized world that has changed dramatically in the 55 years since the Organization was founded. Among its key messages is the need to make globalization more inclusive, to create more opportunities for all, and not leave billions of people in a state of poverty and exclusion.

Malaria Rapid Diagnosis, Making it Work
WHO Meeting Report January 2003

Position of WHO's Roll Back Malaria Department on malaria treatment policy
November 2003
RBM/WHO
WHO recommends that treatment policies for falciparum malaria in all countries experiencing resistance to monotherapies should be combination therapies, preferably those containing an artemisinin derivative.

Anti-Malarial Drug Policies: AFRO
Global AMDP Database [June 2005 Update]
Dr P Olumese
Antimalarial treatment policies for P.falciparum and P.vivax by country in WHO Africa region.

Antimalarial Drug Combination Therapy
Report of a WHO Technical Consultation, 4-5 April 2001, World Health Organization, Geneva
WHO/CDS/RBM/2001.35
Report of a WHO Technical Consultation, held in Geneva, 4-5 April 2001, containing a review of existing data on combination therapy for malaria and identification of specific candidate drugs, especially for Africa.

The Use of Antimalarial Drugs
Report of an Informal Consultation, 13-17 November 2000, World Health Organization, Geneva
WHO/CDS/RBM/2001.33
Report of a WHO Informal Consultation, held in Geneva, 13-17 November 2000. It reviews available antimalarial medicines, presents options for different treatment scenarios according to specific epidemiological situations.

Drug resistance in Malaria
Antimalarial drug resistance hinders malaria control and is therefore a major public health problem. This WHO publication describes the state of knowledge about this problem and outlines the current thinking regarding strategies to limit the advent, spread and intensification of drug-resistant malaria.

The Roll Back Malaria Strategy for Improving Access to Treatment through Home Management of Malaria
WHO/HTM/MAL/2005.1101
This publication presents the available evidence, information, experience and best practices relating to the HMM.

Scaling Up Home-Based Management of Malaria: From Research to Implementation
WHO/HTM/MAL/2004.1096; TDR/IDE/HMM/04.1
Roll Back Malaria Department/UNICEF/UNDP/World Bank, WHO Special Programme for Research and Training in Tropical Diseases
This handbook is the result of consensus reached during a workshop held in Geneva by WHO in January 2002 to share the wealth of information and experience on home-based management of malaria.

A Strategic Framework for Malaria Prevention and Control during Pregnancy in the African Region
AFR/MAL/04/01
AFRO/WHO
The framework describes the burden of malaria in pregnancy, recommends interventions for the prevention and control of malaria during pregnancy, proposes a strategy for delivering interventions in highly endemic areas in the African Region.

Improving Access to Antimalarial Medicines
Report of the RBM Partnership Meeting, 30 September–2 October 2002
WHO/CDS/RBM/2003.44
Key issues in improving access to antimalarial drugs; Antimalarial treatment policy review and implementation: country experiences; Operational research issues.

Procurement of Artemether-Lumefantrine (coartem ®) through WHO
Artemisinin based combination antimalarial treatment available at cost price through WHO for public sector use in developing countries. Full details and downloadable submission form in MSWord format.

WHO position on DDT use in diseasae vector control under the Stockholm Convention on Persistent Organic Pollutants
WHO/HTM/RBM/2004.53
WHO proposed and supports the continued use of DDT for disease vector control, under the Stockholm Convention on Persistent Organic Pollutants (POPs)

Global strategic framework for integrated vector management
WHO/CDS/CPE/PVC/2004.10
The Global Strategic Framework for Integrated Vector Management (IVM) provides a basis for strengthening vector control in a manner that is compatible with national health systems.

Vector control for malaria and other mosquito-borne diseases : report of a WHO study group
WHO TRS 857
WHO Study Group on Vector Control for Malaria and other Mosquito-Borne Diseases (1993 : Geneva, Switzerland)

10 things you need to know about DDT use under the Stockholm Convention
WHO/HTM/RBM/2004.55

Frequently asked questions on DDT use for disease vector control
World Health Organization. 2004

Test procedures for insecticide resistance monitoring in malaria vectors, bio-efficacy and persistence of insecticides on treated surfaces
WHO/CDS/CPC/MAL/98.12
WHO, 1998
Report of the WHO Informal Consultation, 28-30 September 1998, WHO/HQ, Geneva.

Techniques to detect insecticide resistance mechanisms (field and laboratory manual)
WHO/CDS/CPC/MAL/98.6
WHO, 1998
The correct use of biochemical or molecular methods for resistance detection at a mechanistic level can provide a powerful tool for analyzing vector/pest populations with the aim of improving resistance detection and management.

Indoor Residual Spraying against Malaria Vectors
WHO Recommended List
WHOPES
List of WHO recommended insecticides for indoor residual spraying against malaria vectors, containing class group, dosage (g/m2), mode of action, duration of effective action.

WHO Position on DDT Use in Disease Vector Control under The Stockholm Convention on Persistent Organic Pollutants
WHO/HTM/RBM/2004.53
WHO urges that a premature shift to less effective or more costly alternatives to DDT, without adequate preparation of the capacity of Member States will negatively impact on disease burden in the endemic countries.

Guidelines for laboratory and field testing of long-lasting insecticidal mosquito nets
WHO/CDS/WHOPES/GCDPP/2005.11
This document provides procedures and guidelines for testing long-lasting insecticidal mosquito nets (LNs) for personal protection and malaria control and is intended to harmonize the testing procedures carried out to generate data for registration and labeling of such products by national authorities.

Guideline Specifications for Bacterial Larvicides for Public Health Use
WHO/CDS/CPC/WHOPES/99.2
Report of the WHO Informal Consultation, WHO/HQ, Geneva, 28-30 April 1999.

Environmental management for vector control
Training and information materials
Slide set series © 1988, WHO
This set of training aids provides an introduction to the role of water resource management schemes in spreading a number of important communicable diseases of man. It limits itself to those diseases, which are transmitted by invertebrate organisms whose lifecycle, either partly or wholly, is associated with the aquatic environment.